R
Rebecca L. Morgan
Researcher at McMaster University
Publications - 166
Citations - 11078
Rebecca L. Morgan is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Guideline. The author has an hindex of 33, co-authored 127 publications receiving 6458 citations. Previous affiliations of Rebecca L. Morgan include Centers for Disease Control and Prevention.
Papers
More filters
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Bryce D. Smith,Rebecca L. Morgan,Geoff A. Beckett,Yngve Falck-Ytter,Deborah Holtzman,Chong-Gee Teo,Amy Jewett,Brittney Baack,David B. Rein,Nita Patel,Miriam J. Alter,Anthony Yartel,John W. Ward +12 more
TL;DR: Targeted testing and linkage to care for infected persons in this birth cohort is expected to reduce HCV-related morbidity and mortality and help halt disease progression and provide a virologic cure.
Journal ArticleDOI
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Adarsh Bhimraj,Rebecca L. Morgan,Amy Hirsch Shumaker,Valery Lavergne,Lindsey R. Baden,Vincent C.C. Cheng,Kathryn M. Edwards,Rajesh T. Gandhi,William J. Muller,John C. O’Horo,Shmuel Shoham,M. Hassan Murad,Reem A. Mustafa,Shahnaz Sultan,Yngve Falck-Ytter +14 more
TL;DR: It is recommended that patients be recruited into ongoing trials, which would provide much needed evidence on the efficacy and safety of various therapies for COVID-19, given that the authors could not make a determination whether the benefits outweigh harms for most treatments.
Journal ArticleDOI
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies
Rebecca L. Morgan,Brittney Baack,Bryce D. Smith,Anthony Yartel,Marc Pitasi,Yngve Falck-Ytter +5 more
TL;DR: A systematic review of the evidence is needed to assess the benefits of treatment of hepatitis C virus (HCV)-infected persons on development of hepatocellular carcinoma (HCC).
Journal Article
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
Rebecca L. Morgan,Brittney Baack,Bryce D. Smith,Anthony Yartel,Marc Pitasi,Yngve Falck-Ytter +5 more
TL;DR: Sustained virologic response after treatment among HCV-infected persons at any stage of fibrosis is associated with reduced HCC, and the evidence was determined to be of moderate quality.
Journal ArticleDOI
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
Sara E. Oliver,Julia W. Gargano,Mona Marin,Megan J. Wallace,Kathryn G. Curran,Mary Chamberland,Nancy McClung,Doug Campos-Outcalt,Rebecca L. Morgan,Sarah Mbaeyi,Jose R. Romero,H. Keipp Talbot,Grace M. Lee,Beth P. Bell,Kathleen Dooling +14 more
TL;DR: The ACIP recommendation for the use of the Pfizer-BioNTech COVID-19 vaccine under EUA is interim and will be updated as additional information becomes available.